Patent · US Active

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

US9555096B2 · kind B2 · utility

3Cited by
9References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2015
Grant dateJan 31, 2017
Priority date
Expiry dateJun 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors, polyvalent vaccines comprising the recombinant HVT vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.